Hyderabad : T-Hub a startup incubator set up by the Telangana Government said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow, according to a press release issued by the incubator.
As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hub’s mentorship framework and evaluation process, in their respective ventures, it said.
“We are very excited to collaborate with Novartis. It will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster,” Jay Krishnan, CEO, T-Hub said.
Subodh Deshmukh, Global Drug Development India Head, Novartis said, “As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space.
Latest posts by supriya kashyap (see all)
- Natco’s partner Alvogen gets nod for influenza drug in US - November 6, 2017
- USFDA moves to more efficient global pharmaceutical manufacturing inspections - November 6, 2017
- Sanofi refines expectations on drop in sales at diabetes arm - November 6, 2017